[20-1114] American Hospital Association v. Becerra
[20-1114] American Hospital Association v. Becerra  
Podcast: Supreme Court Oral Arguments
Published On: Tue Nov 30 2021
Description: American Hospital Association v. Becerra Wikipedia · Justia (with opinion) · Docket · oyez.org Argued on Nov 30, 2021.Decided on Jun 15, 2022. Petitioner: American Hospital Association, et al..Respondent: Xavier Becerra, Secretary of Health and Human Services, et al.. Advocates: Donald B. Verrilli, Jr. (for the Petitioners) Christopher G. Michel (for the Respondents) Facts of the case (from oyez.org) The federal government reimburses hospitals for providing outpatient care to patients insured by Medicare Part B. Until recently, the government reimbursed all hospitals at a uniform rate for providing covered drugs. In 2018, the Department of Health and Human Services (HHS) reduced the reimbursement rates for certain types of hospitals (known as “340B hospitals”) because those hospitals can obtain the covered drugs far more cheaply than other hospitals can. HHS reasoned that it should not reimburse hospitals more than they paid to acquire the drugs. Several 340B hospitals and hospital associations affected by the decision filed a lawsuit challenging HHS’s decision to lower reimbursement rates. The district court ruled that HHS had exceeded its statutory authority by reducing drug reimbursement rates for 340B hospitals, but the U.S. Court of Appeals for the D.C. Circuit reversed, finding that HHS’s decision is based on a reasonable interpretation of the statute. Question 1. Is the Department of Health and Human Services’ decision to lower drug reimbursement rates for certain hospitals based on a reasonable interpretation of the Medicare statute? 2. Does 42 U.S.C. § 1395l(t)(12) preclude the petitioners’ challenge to HHS’s adjustments? Conclusion The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 does not preclude judicial review of the reimbursement rates set by the Department of Health and Human Services (HHS) for certain outpatient prescription drugs that hospitals provide to Medicare patients. Here, because HHS did not conduct a survey of hospitals’ acquisition costs in 2018 and 2019, its decision to vary reimbursement rates only for 340B hospitals in those years was unlawful. Justice Brett Kavanaugh authored the unanimous opinion of the Court. There is a general presumption that judicial review is available, and the relevant provision of the Medicare act contains nothing precluding judicial review. HHS may not vary the reimbursement rates only for certain hospitals and not others without a survey. Permitting it to do so is contrary to the text and structure of the statute. Thus, its decision to change reimbursement rates only for 340B hospitals without conducting a survey was unlawful.